Laurent Roberto Chiarelli

38PUBLICATIONS
80CO-AUTHORS
Medical mycologyMedical biotechnology diagnostics (incl. biosensors)Epidemiological modellingMedical devicesMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Oct 07, 2026
Human prostaglandin reductases dearomatize and inactivate benzothiazinone antitubercular drugs.

|Jul 08, 2026
Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in Mycobacterium tuberculosis.

|May 13, 2026
The Differential Redox Resilience of Alvelestat and Sivelestat: A Mechanistic Hypothesis for Inhibitor Performance Under Oxidative Stress.

|Apr 17, 2026
Discovery of Potent Benzoselenazinone-Based DprE1 Inhibitors: A Novel Selenium-Containing Scaffold with Superior Anti-TB Activity and Pharmacokinetic Properties.

|Dec 22, 2025
Uncovering Insights Into the Biology of Mycobacterium tuberculosis Using Genetic Tools.

Alessandro Stamilla, Deborah Recchia, Giovanni Stelitano

|Jul 29, 2025
Repurposing of FDA-Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach.

Giovanni Stelitano, Christian Bettoni, Matteo Mori

Pageof 7

Frequent Collaborators

18 joint publications

Giovanni Stelitano

11 joint publications

Maria Rosalia Pasca

10 joint publications

Matteo Mori

9 joint publications

Fiorella Meneghetti